Thomas Jefferson University Sidney Kimmel Cancer Center—Jefferson Health (SKCC) completed a study revealing that the chemotherapeutic agent abemaciclib, currently effective in treating breast cancer, provides evidence supporting the use of the therapy for pancreatic...